Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 12, 2012 - Issue 12
Submit an article Journal homepage
16
Views
3
CrossRef citations to date
0
Altmetric
Theme: Kidney Cancer - Editorial

A vaccine in renal cell carcinoma: are we nearing reality?

Jens Bedke Department of Urology, University of Tübingen, Germany. [email protected].
,
Cécile Gouttefangeas Department of Immunology, University of Tübingen, Germany
,
Stephan Kruck Department of Urology, University of Tübingen, Germany
&
Arnulf Stenzl Department of Urology, University of Tübingen, Germany
Pages 1503-1505 | Published online: 10 Jan 2014

References

  • Ljungberg B, Campbell SC, Choi HY et al. The epidemiology of renal cell carcinoma. Eur. Urol. 60(4), 615–621 (2011).
  • Ljungberg B, Cowan NC, Hanbury DC et al.; European Association of Urology Guideline Group. EAU guidelines on renal cell carcinoma: the 2010 update. Eur. Urol. 58(3), 398–406 (2010).
  • Wright JC. Update in cancer chemotherapy: genitourinary tract cancer, Part 1. J. Natl Med. Assoc. 79(12), 1249–1258 (1987).
  • Kruck S, Bedke J, Kuczyk MA, Merseburger AS. Second-line systemic therapy for the treatment of metastatic renal cell cancer. Expert Rev. Anticancer Ther. 12(6), 777–785 (2012).
  • Yang JC, Sherry RM, Steinberg SM et al. Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer. J. Clin. Oncol. 21(16), 3127–3132 (2003).
  • Ahmadzadeh M, Rosenberg SA. IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients. Blood 107(6), 2409–2414 (2006).
  • Brookman-May S, Burger M, Wieland WF, Rössler W, May M, Denzinger S. Vaccination therapy in renal cell carcinoma: current position and future options in metastatic and localized disease. Expert Rev. Vaccines 10(6), 837–852 (2011).
  • Walter S, Weinschenk T, Stenzl A et al. Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat. Med. doi:10.1038/nm.2883 (2012) (Epub ahead of print).
  • Hoos A, Eggermont AM, Janetzki S et al. Improved end points for cancer immunotherapy trials. J. Natl Cancer Inst. 102(18), 1388–1397 (2010).
  • Palucka K, Banchereau J. Cancer immunotherapy via dendritic cells. Nat. Rev. Cancer 12(4), 265–277 (2012).
  • Seremet T, Brasseur F, Coulie PG. Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy. Cancer J. 17(5), 325–330 (2011).
  • Hodi FS, O’Day SJ, McDermott DF et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363(8), 711–723 (2010).
  • Finke JH, Rini B, Ireland J et al. Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients. Clin. Cancer Res. 14(20), 6674–6682 (2008).
  • Hipp MM, Hilf N, Walter S et al. Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses. Blood 111(12), 5610–5620 (2008).
  • Ko JS, Zea AH, Rini BI et al. Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients. Clin. Cancer Res. 15(6), 2148–2157 (2009).
  • Bedke J, Laske K, Feyerabend S et al. Clinical and immunological monitoring of a multi-peptide vaccination trial in patients with stage III renal cell carcinoma. Eur. Urol. Suppl. 11, e76 (2012).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.